Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
6
×
life sciences
migraine
6
×
national blog main
clinical trials
eli lilly
indiana blog main
indiana top stories
national
national top stories
new york blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
lasmiditan
teva pharmaceutical
allergan
american academy of neurology
biohaven
calcitonin gene-related peptide
cancer
cancer immunotherapy
What
new
bio
class
fda
migraine
roundup
approval
approved
companies
drug
drugs
ipo
life
medicines
science
week
won
adults
allergan
america
announced
arena’s
arguments
bails
big
biogen
bounty
brand
bridgebio
capital
car
cig
comeback
commercialized
competitors
continues
convoluted
corner
deals
decades
Language
unset
Current search:
migraine
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines